WallStreetZenWallStreetZen

NASDAQ: HOTH
Hoth Therapeutics Inc Stock Ownership - Who owns Hoth Therapeutics?

Insider buying vs selling

Have Hoth Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when HOTH insiders and whales buy or sell their stock.

HOTH Shareholders

What type of owners hold Hoth Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Anthony Hayes75.94%3,300,516$4.42MInsider
Aikido Pharma Inc26.01%1,130,674$1.52MInsider
Robb Knie19.06%828,259$1.11MInsider
Kenneth L. Rice Jr.17.88%776,943$1.04MInsider
Kevin Jess Poor17.26%750,000$1.01MInsider
Matthew D. Eitner17.26%750,000$1.01MInsider
James P. Ahern17.26%750,000$1.01MInsider
Vanguard Group Inc0.89%38,804$52.00kInstitution
Vadim Mats0.86%37,500$50.25kInsider
David Sarnoff0.58%25,000$33.50kInsider

1 of 3

HOTH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HOTH0.94%99.06%
TCON6.34%93.66%Net Selling
KZIA2.14%9.76%
CELZ1.42%3.86%Net Buying
MYMD46.54%53.46%Net Buying

Hoth Therapeutics Stock Ownership FAQ

Who owns Hoth Therapeutics?

Hoth Therapeutics (NASDAQ: HOTH) is owned by 1.82% institutional shareholders, 192.36% Hoth Therapeutics insiders, and 0.00% retail investors. Anthony Hayes is the largest individual Hoth Therapeutics shareholder, owning 3.30M shares representing 75.94% of the company. Anthony Hayes's Hoth Therapeutics shares are currently valued at $4.42M.

If you're new to stock investing, here's how to buy Hoth Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.